Cynosure to Acquire MyEllevate, Innovative Minimally Invasive Facial Rejuvenation Treatment
Deal expands Cynosure s best-in-class portfolio with addition of MyEllevate Surgical Suture System
News provided by
Share this article
Share this article
WESTFORD, Mass., April 30, 2021 /PRNewswire/ Cynosure announced today at The Aesthetic Society s The Aesthetic Meeting 2021 that it has entered into an agreement to acquire the MyEllevate
® Surgical Suture System, expanding the Company s portfolio of minimally invasive facial rejuvenation solutions. Harnessing the power of the patented ICLED
® light guided suture system, MyEllevate allows practitioners to easily place a suture support system without incisions, helping patients restore a youthful appearance with minimal downtime. Cynosure and MyEllevate will both be exhibiting at the meeting.